Propanc Biopharma, Inc. Uncategorized Contracts & Agreements

32 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Maturity Extension Agreement dated May 10, 2024
Propanc Biopharma, Inc.
2024
Equity Line Agreement, dated July 20, 2023, by and between the Company and the Investor
Propanc Biopharma, Inc.
2023
Equity Line Agreement, dated November 3, 2022, by and between the Company and the Investor
Propanc Biopharma, Inc.
2023
Consultant Agreement by and between the Company and Paul Patrizio, dated October 1, 2021
Propanc Biopharma, Inc.
Biotechnology
NJ
2021
Amended and Restated Director Agreement, by and between the Company and Josef Zelinger, dated August 12, 2021
Propanc Biopharma, Inc.
Biotechnology
2021
Cancellation Agreement, by and between the Company and Dr. Julian Kenyon, dated August 12, 2021
Propanc Biopharma, Inc.
Biotechnology
DE
2021
Cancellation Agreement, by and between the Company and James Nathanielsz, dated August 12, 2021
Propanc Biopharma, Inc.
Biotechnology
DE
2021
Director Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger
Propanc Biopharma, Inc.
Biotechnology
2020
[Signaturepage follows]
Propanc Biopharma, Inc.
Biotechnology
NY
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
NY
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
2017
40 Wall Street | New York, NY | 10005 p. 347 ###-###-#### | f. 646 ###-###-####
Propanc Biopharma, Inc.
Biotechnology
2017
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE JANUARY 27, 2018
Propanc Biopharma, Inc.
2017
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE DECEMBER 21, 2017
Propanc Biopharma, Inc.
2016
[PROPANC HEALTH GROUP CORPORATION LETTERHEAD]
Propanc Biopharma, Inc.
Biotechnology
2016
JUNIOR SUBORDINATED PROMISSORYNOTE
Propanc Biopharma, Inc.
2016
[Signaturepage follows.]
Propanc Biopharma, Inc.
2016
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE OCTOBER 31, 2017
Propanc Biopharma, Inc.
2016
ADDITIONAL ISSUANCE AGREEMENT
Propanc Biopharma, Inc.
2016
QUALITY ASSURANCE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
2016
Level2, 555 Riversdale Road, Camberwell, Victoria, 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com
Propanc Biopharma, Inc.
Biotechnology
2016
Level 2, 555 Riversdale Road, Camberwell, Victoria 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com
Propanc Biopharma, Inc.
Biotechnology
2016
AMENDMENTNO. 1 TO EMPLOYMENTAGREEMENT
Propanc Biopharma, Inc.
Biotechnology
2016
Dated 20XX PROPANC and [INSERT NAME] _______________________________________________ SCIENTIFIC ADVISORYBOARD MEMBER AGREEMENT _______________________________________________...
Propanc Biopharma, Inc.
2016
DirectorAgreement
Propanc Biopharma, Inc.
Biotechnology
NV
2016
EmploymentAgreement
Propanc Biopharma, Inc.
Biotechnology
NV
2016
ADDENDUM
Propanc Biopharma, Inc.
Biotechnology
2016
SECURITYAGREEMENT
Propanc Biopharma, Inc.
2015
Limited Distributor Deed
Propanc Biopharma, Inc.
Biotechnology
2011
EXHIBIT 10.12 UNIVERSITY OF BATH Dated: 18 July 2008 (1) UNIVERSITY OF BATH (2) PROPANC PTY LTD RESEARCH AGREEMENT IN THE DEPARTMENT OF BIOLOGY AND BIOCHEMISTRY RELATING TO...
Propanc Biopharma, Inc.
Biotechnology
2011